AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AHR - US3981823038 - REIT
50.43 USD
0 (0%)
Taking everything into account, AHR scores 3 out of 10 in our fundamental rating. AHR was compared to 128 industry peers in the Diversified REITs industry. AHR may be in some trouble as it scores bad on both profitability and health. AHR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AHR had positive earnings in the past year.
In the past year AHR had a positive cash flow from operations.
1.2 Ratios
AHR's Return On Assets of 0.57% is in line compared to the rest of the industry. AHR outperforms 49.22% of its industry peers.
AHR has a Return On Equity (1.02%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.09%, AHR is doing good in the industry, outperforming 60.16% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AHR is in line with the industry average of 3.06%.
The 3 year average ROIC (1.94%) for AHR is below the current ROIC(3.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.57% | ||
| ROE | 1.02% | ||
| ROIC | 3.09% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
AHR has a Profit Margin of 1.24%. This is comparable to the rest of the industry: AHR outperforms 46.88% of its industry peers.
AHR's Operating Margin of 7.70% is on the low side compared to the rest of the industry. AHR is outperformed by 81.25% of its industry peers.
In the last couple of years the Operating Margin of AHR has grown nicely.
AHR's Gross Margin of 20.69% is on the low side compared to the rest of the industry. AHR is outperformed by 92.19% of its industry peers.
AHR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.7% | ||
| PM (TTM) | 1.24% | ||
| GM | 20.69% |
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
2. Health
2.1 Basic Checks
AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AHR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AHR has an improved debt to assets ratio.
2.2 Solvency
AHR has an Altman-Z score of 2.67. This is not the best score and indicates that AHR is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.67, AHR belongs to the best of the industry, outperforming 96.09% of the companies in the same industry.
AHR has a Debt/Equity ratio of 0.58. This is a neutral value indicating AHR is somewhat dependend on debt financing.
AHR has a Debt to Equity ratio of 0.58. This is amongst the best in the industry. AHR outperforms 85.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.67 |
ROIC/WACC0.39
WACC7.82%
2.3 Liquidity
AHR has a Current Ratio of 0.76. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR's Current ratio of 0.76 is on the low side compared to the rest of the industry. AHR is outperformed by 65.63% of its industry peers.
AHR has a Quick Ratio of 0.76. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR has a worse Quick ratio (0.76) than 63.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
AHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 155.32%, which is quite impressive.
The Revenue has grown by 9.36% in the past year. This is quite good.
The Revenue has been growing by 17.32% on average over the past years. This is quite good.
EPS 1Y (TTM)155.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
Revenue 1Y (TTM)9.36%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%9.38%
3.2 Future
AHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.57% yearly.
AHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.44% yearly.
EPS Next Y230.93%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y7.91%
Revenue Next 3Y8.13%
Revenue Next 5Y10.44%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 193.96 indicates a quite expensive valuation of AHR.
Based on the Price/Earnings ratio, AHR is valued a bit more expensive than 61.72% of the companies in the same industry.
AHR is valuated expensively when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
AHR is valuated quite expensively with a Price/Forward Earnings ratio of 62.41.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AHR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, AHR is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 193.96 | ||
| Fwd PE | 62.41 |
4.2 Price Multiples
AHR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AHR is more expensive than 94.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 29.72 |
4.3 Compensation for Growth
AHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AHR's earnings are expected to grow with 79.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y123.44%
EPS Next 3Y79.57%
5. Dividend
5.1 Amount
AHR has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.98, AHR pays less dividend than the industry average, which is at 6.34. 86.72% of the companies listed in the same industry pay a better dividend than AHR!
Compared to an average S&P500 Dividend Yield of 2.32, AHR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
5.2 History
AHR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
583.20% of the earnings are spent on dividend by AHR. This is not a sustainable payout ratio.
DP583.2%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
NYSE:AHR (12/2/2025, 10:29:04 AM)
50.43
0 (0%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners90.78%
Inst Owner Change3.74%
Ins Owners0.82%
Ins Owner Change-0.1%
Market Cap8.95B
Revenue(TTM)2.20B
Net Income(TTM)27.26M
Analysts83.75
Price Target53.3 (5.69%)
Short Float %1.79%
Short Ratio1.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP583.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.29%
Min EPS beat(2)33.28%
Max EPS beat(2)53.31%
EPS beat(4)3
Avg EPS beat(4)-50.49%
Min EPS beat(4)-359.9%
Max EPS beat(4)71.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.6%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)2.57%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.57%
Revenue beat(8)4
Avg Revenue beat(8)0.94%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.57%
PT rev (3m)19.24%
EPS NQ rev (1m)-7.25%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.78%
Revenue NQ rev (1m)4.05%
Revenue NQ rev (3m)3.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 193.96 | ||
| Fwd PE | 62.41 | ||
| P/S | 4.07 | ||
| P/FCF | N/A | ||
| P/OCF | 29.94 | ||
| P/B | 3.34 | ||
| P/tB | 3.96 | ||
| EV/EBITDA | 29.72 |
EPS(TTM)0.26
EY0.52%
EPS(NY)0.81
Fwd EY1.6%
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)1.68
OCFY3.34%
SpS12.39
BVpS15.1
TBVpS12.75
PEG (NY)0.84
PEG (5Y)N/A
Graham Number9.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.57% | ||
| ROE | 1.02% | ||
| ROCE | 3.91% | ||
| ROIC | 3.09% | ||
| ROICexc | 3.2% | ||
| ROICexgc | 3.59% | ||
| OM | 7.7% | ||
| PM (TTM) | 1.24% | ||
| GM | 20.69% | ||
| FCFM | N/A |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexgc growth 3Y56.38%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.46 | ||
| Cap/Depr | 256.07% | ||
| Cap/Sales | 20.86% | ||
| Interest Coverage | 1.95 | ||
| Cash Conversion | 85.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | 2.67 |
F-Score8
WACC7.82%
ROIC/WACC0.39
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
EPS Next Y230.93%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
EPS Next 5YN/A
Revenue 1Y (TTM)9.36%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%9.38%
Revenue Next Year8.67%
Revenue Next 2Y7.91%
Revenue Next 3Y8.13%
Revenue Next 5Y10.44%
EBIT growth 1Y34.52%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year157.32%
EBIT Next 3Y49.12%
EBIT Next 5Y38.05%
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A
AMERICAN HEALTHCARE REIT INC / AHR FAQ
Can you provide the ChartMill fundamental rating for AMERICAN HEALTHCARE REIT INC?
ChartMill assigns a fundamental rating of 3 / 10 to AHR.
What is the valuation status for AHR stock?
ChartMill assigns a valuation rating of 2 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.
What is the profitability of AHR stock?
AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 3 / 10.
How financially healthy is AMERICAN HEALTHCARE REIT INC?
The financial health rating of AMERICAN HEALTHCARE REIT INC (AHR) is 3 / 10.
What is the earnings growth outlook for AMERICAN HEALTHCARE REIT INC?
The Earnings per Share (EPS) of AMERICAN HEALTHCARE REIT INC (AHR) is expected to grow by 230.93% in the next year.